1.Observation on clinical effect of percutaneous vertebroplasty for treating old unstable osteoporotic vertebral fracture
Lijun WANG ; Xiujiang YANG ; Zhenming HU ; Jian LIU ; Peng TANG ; Yaokai HUANG
Chongqing Medicine 2017;46(9):1208-1210
Objective To explore the clinical effect of percutaneous vertebroplasty (PVP) in the treatment of old unstable osteoporotic vertebral fracture.Methods Twenty cases of old unstable osteoporotic single vertebral body fracture were divided into the stable group and unstable group according to the imaging results,10 cases in each group.PVP was performed in all 20 cases.The VAS scores of waist bending activity at preoperative 30 min,postoperative 6 h,3,30 d were observed.The changes of anterior edge height of spinal body in the injured vertebral segment of erect position and horizontal position were compared before and after operation.Results The VAS score of waist bending at preoperative 30 min had statistical difference between the two groups (P<0.05).Compared with at preoperative 30 min,the VAS scores at postoperative observation points in the two groups were significantly decreased with statistical difference (P<0.05).The VAS scores at postoperative 6 h,3,30 d had no statistical difference between the two groups(P>0.05).The changes of posterior edge height of spinal body in the stable groups had no statistical difference before and after operation (P>0.05);the anterior edge height of spinal body after treatment in the unstable group were significantly changed compared with before operation,and the difference was statistically significant(P<0.05).Conclusion Preoperative pain in the patients with unstable osteoporotic vertebral fracture is more obvious than that in the patients with stable osteoporotic vertebral fracture.But all have similar effect after PVP therapy;the postoperative height in unstable osteoporotic vertebral fracture can obtain a certain recovery after PVP.
2.Disease spectrum and prognostic factors of 499 cases of acquired immune deficiency syndrome complicated with central nervous system infections in Chongqing
Yanqiu LU ; Xiaojie HUANG ; Min LIU ; Yushan WU ; Hao WU ; Hongzhou LU ; Yaokai CHEN
Chinese Journal of Infectious Diseases 2018;36(2):65-68
Objective To describe the disease spectrum,morbidity,mortality and prognostic factors of acquired immune deficiency syndrome (AIDS) patients complicated with central nervous system (CNS) infections.Methods The data of 4 426 AIDS patients from February 2013 to February 2017 in Chongqing public health medical center were collected,among which 499 cases had CNS infection.The morbidity and mortality of CNS infections were calculated.Association between different CNS infections and CD4+T cell counts was analyzed.Prognostic factors for the outcome of hospitalization were also studied.Mann-Whitney U test was used for continuous variables.Univariate and multivariate analyses were performed by logistic regression analysis.Results The morbidity of CNS infections in AIDS patients was 11.27% (499/4 426).The most prevalent CNS infections were tuberculous meningitis (4.50%),cryptococcal meningitis (3.25 %) and CNS infections with unknown etiology (1.11 %).The mortality rate was 18.84% (94/499),among which tuberculous meningitis accounted for 35 cases (17.59%),cryptococcal meningitis 23 cases (15.79%) and CNS infections with unknown etiology 19 cases (38.76%).The average CD4-T cell count level in those who died were significantly lower than that in those who survived (Z=2.51,P =0.001).Visual impairment,nuchal rigidity,positive pathologic reflexes,consciousness disturbance,CD4+T cell counts<50 cells/μL and HIV RNA≥5 lg copies/mL at baseline were independent prognostic factors for mortality.Conclusions The morbidity and mortality of CNS infections are high among AIDS patients in Chongqing,and those patients with severe immunosuppression are usually affected.Older age,consciousness disturtance and severe immunosuppression are three independent risk factors for mortality.
3.Efficacy and safety of trimethoprim/sulfamethoxazole combined with caspofungin for the treatment of acquired immunodeficiency syndrome patients with moderate to severe pneumocystis pneumonia
Xiaoqing HE ; Yinqiu HUANG ; Yuanyuan QIN ; Yanming ZENG ; Yanqiu LU ; Yaokai CHEN
Chinese Journal of Infectious Diseases 2023;41(4):255-262
Objective:To assess the efficacy and safety of trimethoprim/sulfamethoxazole (TMP/SMZ) combined with caspofungin for the treatment of acquired immunodeficiency syndrome (AIDS)patients with moderate to severe pneumocystis pneumonia (PCP) requiring mechanical ventilation.Methods:The clinical data of AIDS patients who admitted to Chongqing Public Health Medical Center from March 1, 2019 to March 1, 2021 with moderate to severe PCP requiring mechanical ventilation were retrospectively analyzed. Clinical characteristics and outcomes were compared between two groups receiving either combination therapy with TMP/SMZ and caspofungin (combination therapy group) or TMP/SMZ monotherapy (monotherapy group). The patients were divided into two subgroups according to the baseline arterial partial pressure of oxygen (PaO 2), patients with arterial PaO 2≥50 mmHg (1 mmHg=0.133 kPa) and PaO 2 <50 mmHg. The clinical efficacies of combination therapy and monotherapy in each subgroup were further compared. Chi-square and Fisher exact test were used for statistical analysis. The three-month survival was estimated by the Kaplan-Meier method, and the three-month survival rates were compared by Log-rank method. Results:A total of 83 patients were enrolled, including 23 in the monotherapy group and 60 in the combination therapy group. There was no significant difference in all-cause hospital mortalities between these two groups (34.8%(8/23) vs 23.3%(14/60), χ2=1.12, P=0.290). Kaplan-Meier survival curves indicated no significant difference in the three-month survival rates between the two groups ( χ2=0.51, P=0.477). There ware no significant differences observed in the positive clinical response rates and the mechanical ventilation rates after seven days of anti-PCP treatment between the two groups ( χ2=0.02 and 0.01, respectively, both P>0.05). In the 52 patients with PaO 2≥50 mmHg, no significant difference in all-cause hospital mortalities was observed between the monotherapy group and the combination therapy group (2/13 vs 25.6%(10/39), χ2=0.14, P=0.704). There was no statistical significance in the three-month survival rates between the two groups ( χ2=0.69, P=0.407). No significant difference was observed either in the clinical positive response rates or the mechanical ventilation rates after seven days of anti-PCP treatment between the two group( χ2=1.02 and 0.69, respectively, both P>0.05). In the 31 patients with PaO 2<50 mmHg, the all-cause hospital mortality in the combination therapy group was 19.0%(4/21), while six of the 10 patients in the monotherapy group died, and the difference was statistically significant (Fisher exact test, P=0.040). The three-month survival rate in the combination therapy group was significantly higher than that in the monotherapy group ( χ2=4.09, P=0.043). There were no significant differences in clinical positive response rate and the mechanical ventilation rate after seven days of anti-PCP treatment between the two group (Fisher exact test, both P>0.05). The overall adverse event rate in the monotherapy group was 87.0%(20/23), with an incidence of 56.5%(13/23) for both electrolyte disturbances and bone marrow suppression. The above incidences in the combination therapy group were 78.3%(47/60), 35.0%(21/60) and 53.3%(32/60), respectively, and all differences were not statistically significant ( χ2=0.34, 3.18 and 0.07, respectively, all P>0.05). Conclusions:The efficacy of combination therapy with TMP/SMZ and caspofungin is comparable to that of TMP/SMZ monotherapy in AIDS patients with moderate to severe PCP requiring mechanical ventilation. However, in AIDS patients with PCP requiring mechanical ventilation with the baseline PaO 2<50 mmHg, the efficacy of combination therapy is statistically superior to that of TMP/SMZ monotherapy. Combination therapy does not increase the risk of adverse events.
4.A retrospective study on prognostic factors of cryptococcal meningitis in 203 patients with acquired immunodeficiency syndrome
Yanqiu LU ; Xiaojie HUANG ; Yushan WU ; Min LIU ; Hao WU ; Hongzhou LU ; Yaokai CHEN
Chinese Journal of Neuromedicine 2018;17(4):397-401
Objective To explore the mortality and prognostic factors of cryptococcal meningitis (CM) in patients with acquired immunodeficiency syndrome (AIDS).Methods We collected the clinical data of all the 203 AIDS patients complicated with CM who had been treated between December 2010 and March 2017 in Chongqing Public Health Medical Center.They were followed up by telephone periodically after hospital discharge and their survival or death was recorded.Their overall mortality rate,survival curves and prognostic factors were then analyzed.Results Of the 203 cases included in this study,92.6% had CD4+ T cell counts ≤100 cells/μL,50.3% HIV RNA>5 lg copies/mL,and 64.5% intracranial pressure ≥250 mmH2O.Their mortality during hospital stay was 9.9%(20/203),mortality during follow-up 16.2% (24/148) and overall mortality 26.1%.Their survival rate declined rapidly during the first 2 weeks after disease onset,and their accumulated mortality was close to 25.0% at week 10 but stabilized thereafter.The patients aged between 18 and 44 years had a significantly lower risk of death than those of other age groups,showing that age was an independent protective prognostic factor (AOR=0.228,P=0.036,95%CI:0.057~0.910).Consciousness disorder was an independent risk factor for death (AOR=7.001,P=0.035,95% CI:1.143~42.882).Conclusions AIDS patients complicated with CM may face a high mortality and death may mostly occur within the first 3 months after disease onset.Those with a younger age may have relatively better prognosis.Consciousness disorder is a risk factor of death.
5.Study on Quality Consistency of Traditional Chinese Medicine
Xingbao TAO ; Yinqiu HUANG ; Bin HONG ; Lvlang ZHANG ; Yaokai CHEN
World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(11):1781-1786
This study was aimed to establish a suitable consistency evaluation system according to the existing problems in the quality evaluation of traditional Chinese medicine (TCM) for the development of Chinese medicine industry.Based on the particularity of TCM,combined with the advanced technology of TCM quality evaluation through the construction of TCM quality consistency evaluation system,this study explored a new quality evaluation method for seeking new breakthrough.The results showed that a new quality evaluation model of TCM using multiple indexes,which included "trait evaluation + chemical evaluation + biological evaluation" to achieve the consistency of TCM by effective combinations.It was concluded that the exploration provided some references for the evaluation of quality consistency of TCM.